GBA Presents: House of Gummy-!

Concerning Space stocks.

RKLB has been our play off and on a few times. We like the name.

Rocket Lab USA, Inc. (NASDAQ:RKLB), a California-based space firm, has been leading the way with rocket launches and returns. Peter Beck, the CEO of Rocket Lab USA, Inc. (NASDAQ:RKLB), recently highlighted, during the third quarter earnings call, some of the growth plans of his firm moving into 2024. He also shed light on the performance of his company during the 2023 fiscal year.

“Starting with Electron, in July, we launched a mission with several satellites for NASA and others, which was the first of the two back-to-back reusability focused missions. After successfully deploying the first Mission 7 spacecraft, Electron’s first stage was bought back to Earth and recovered from the ocean. Then we followed that up with our 40th Electron launch and even more recovery milestones, including a return for stage and thea first launch, reflowing Rutherford engine previously flown on our 26 Mission, There and Back Again. The engine performed flawlessly like a new one, completely validating our pursuit of reusability for Electron and setting us up well to refly an entire engine set as our next major reusability goal. Next, I will provide a bit of an update for Electron. Following those two successful flights, as you know, we unfortunately experienced an anomaly on our 41st Mission. It’s important to remember that up until this launch, we have had 37 successful orbital missions to place 171 satellites in orbit. And the past two years have been flawless, with a record of 20 successful missions one after the other."


What I am thinking is SPAC X goes public in 2024 and ignites this sector.



I'm going to have to check my sale price here but as I remember it was in the high $4's.

Not the best look-

Rocket Lab USA, Inc. (RKLB)
NasdaqCM - NasdaqCM Real Time Price.
5.55+0.15(+2.78%)
At close: January 8 04:00PM EST
5.68+0.13(+2.34%) :(
Pre-Market:07:39AM EST
 
--Shift4 Payments price target raised by $8 at Piper Sandler, » 07:22 FOUR

--Apellis price target raised by $4 at BofA, » 07:11 APLS

--Socket Mobile announces DuraSled models for iPhone 15 » 06:20 SCKT

--Citi opens 'positive catalyst watch' on XPO into earnings » 06:15 XPO

XPO Schedules Fourth Quarter 2023 Earnings Conference Call for Wednesday, February 7, 2024

 
I can't even explain how moronic Cramer is. After panicking and selling tech
he told his viewers they had to be back in the names yesterday. Today I bet we go down.
 
We know AI and Biotech are going to intercept each other often in the future.

Company Profile
WGS

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It also provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. is headquartered in Stamford, Connecticut.
 
There are two health related stks I am more or less favoring. Hims & Hers and there you can get generic Viagra and such....

and TDOC.

Both are plays off the weight loss drugs. Lose weight.. go on Dating site & get generic Viagra it's a straight line of thinking.

But with TDOC also... we have the suicide talk down which is in great need now and these skinny monsters lose their minds. (side effect)

Employers seeking virtual care to manage demand for weight loss drugs: report

It takes some guts but TDOC is a buy./////
 
Back
Top